Table 7. Comparative ADMET profile of the test ligands and the control.
| Compounds | Blood-Brain Barrier (BBB+/BBB-) | Human Intestinal Absorption(HIA) | AMES toxicity | Carcinogenicity | LD50 in rat |
| CID 126941 (Methotrexate) | 0.9467 (BBB-) | 0.8261 (HIA+) | 0.9132 (Non AMES Toxic) | Non- carcinogenic | 3.4955 |
| CID 5161 (Salsalate) | 0.8946 (BBB+) | 0.9161 (HIA+) | 0.9731 (Non AMES Toxic) | Non- carcinogenic | 2.4607 |
| CID (122677576) | 0.6563 (BBB-) | 0.9575 (HIA+) | 0.7703 (Non AMES Toxic) | Non- carcinogenic | 2.6698 |
| CID (102026478) | 0.9467 (BBB-) | 0.8261 (HIA+) | 0.9132 (Non AMES Toxic) | Non- carcinogenic | 3.4955 |